SYROS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, after Year Five
SYROS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, after Year Five of $1.67 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2020-08-06
- 2020-06-30: Long-Term Debt, Maturity, after Year Five $1.67M.
- 2020-03-31: Long-Term Debt, Maturity, after Year Five $1.67M.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2020-06-30 | $1.67M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.67M 10-Q · filed 2020-05-07 |